Correction to “Phage‐Derived Oncolytic Viruses with 3C From Seneca Valley Virus for Targeted Therapy of Cervical Cancer”

Documenti analoghi

• Oncolytic Viruses in Cancer Immunotherapy
  di: Xiao Li, et al.
  Pubblicazione: (2024)
• Stable Biotherapeutic Penetration Screening in Critically Small Colorectal Metastatic Cancer Biopsies Allows for Oncolytic Virus‐Delivered Chemotherapeutic Response Assessment through 3D Bioprinted Organoid Expansion
  di: Colin McGuckin, et al.
  Pubblicazione: (2024)
• Nanotechnologies Targeting Traumatic Brain Injury: From Diagnosis to Targeted Therapy
  di: Kunyao Xu, et al.
  Pubblicazione: (2025)
• Nanoparticles in Active Targeting Strategies for Cancer Therapy: Advancing Frontiers in Chemotherapy Enhancement
  di: Xudong Zheng, et al.
  Pubblicazione: (2026)
• Correction to “Fluorinated Chitosan‐Mediated Transepithelial Delivery of Intravesical Dual‐Drug Immunotherapeutic for Bladder Cancer Therapy”
  Pubblicazione: (2025)